Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,392,615 papers from all fields of science
Search
Sign In
Create Free Account
fazarabine
Known as:
5 azacytosine arabinoside
, Kymarabine
, arabinosyl-5-azacytosine
Expand
An orally-active pyrimidine analogue of an aza-substituted cytidine in which the ribose moiety is replaced by an arabinose sugar. Similar in action…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (4)
Antineoplastic Agents
Azacitidine
Cytarabine
Nucleoside Analogs
DNA Synthesis Inhibition
DNA-Directed DNA Polymerase
analogs & derivatives
Narrower (1)
NSC 281272
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia
W. Waud
,
S. Harrison
,
Karen S. Gilbert
,
W. R. Laster
,
D. Griswold
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 10159177
SummarySince 1978, over 50 clinically useful antitumor drugs or new candidate antitumor agents have been evaluated in vivo…
Expand
1992
1992
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma
E. Casper
,
G. Schwartz
,
D. Kelsen
Investigational new drugs
1992
Corpus ID: 19703977
We conducted a phase II evaluation of fazarabine 1.75–2.0 mg/m2hr over 72 hours every 28 days in 14 previously untreated patients…
Expand
1990
1990
Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
Jean L. Grem
,
Carmen J. Allegra
Cancer Research
1990
Corpus ID: 28280215
We evaluated the interaction of a biochemically active concentration of cyclopentenyl cytosine (CPE-C), an investigational…
Expand
1989
1989
Phase I trial and pharmacokinetic evaluation of fazarabine in children.
R. Heideman
,
A. Gillespie
,
+7 authors
D. Poplack
Cancer Research
1989
Corpus ID: 15212342
A phase I trial of fazarabine (1-beta-D-arabinofuranosyl-5-azacytosine, NSC 281272) administered as a 24-h continuous infusion…
Expand
Review
1987
Review
1987
Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials
J. Grem
,
D. Shoemaker
,
+7 authors
B. Leyland-Jones
Investigational new drugs
1987
Corpus ID: 4366518
Arabinosyl-5-azacytosine is a new compound which has been selected by the Division of Cancer Treatment, National Cancer Institute…
Expand
1986
1986
Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
J. Veselý
,
A. Pískala
Neoplasma (Bratislava)
1986
Corpus ID: 33905206
Ara-5AC depresses the growth of L1210 cells in vivo in a manner that is schedule-independent and at the dose levels which are…
Expand
1986
1986
Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.
M. Dalal
,
J. Plowman
,
+6 authors
D. Johns
Cancer Research
1986
Corpus ID: 12243317
Arabinofuranosyl-5-azacytosine (ara-AC), a nucleoside combining the structural elements of 5-azacytidine and…
Expand
1985
1985
Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
A. Townsend
,
J. Leclerc
,
G. Dutschman
,
D. Cooney
,
Y. Cheng
Cancer Research
1985
Corpus ID: 44742829
1-beta-D-Arabinofuranosyl-5-azacytosine (ara-5-aza-Cyd) had potent cytotoxicity against human T-type lymphoblastic cells in…
Expand
1979
1979
Synthesis and antitumor activity of 5-azacytosine arabinoside.
J. Beisler
,
M. Abbasi
,
J. Driscoll
Journal of Medicinal Chemistry
1979
Corpus ID: 7690440
5-Azacytosine arabinoside (ara-AC) can be considered a combination of structural elements derived from the antitumor nucleosides…
Expand
1977
1977
The synthesis and antitumor activity of arabinosyl-5-azacytosine.
J. Beisler
,
M. Abbasi
,
J. Driscoll
Biochemical Pharmacology
1977
Corpus ID: 37195411
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE